ApoA-II modulates the association of HDL with class B scavenger receptors SR-BI and CD36

Journal of Lipid Research

Volumn 45, Issue 4, 2004, Pages 706-715

  De Beer, Maria C ^a,b   Castellani, Lawrence W ^c   Cai, Lei ^a,b   Stromberg, Arnold J ^d   De Beer, Frederick C ^a,b   Van Der Westhuyzen, Deneys R ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Apolipoprotein A II; Atherosclerosis; High density lipoprotein; Lipoprotein metabolism; Selective lipid uptake

Indexed keywords

APOLIPOPROTEIN A2; CD36 ANTIGEN; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD36; APOLIPOPROTEIN A-II; BIOLOGICAL TRANSPORT; CHOLESTEROL ESTERS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS B;

EID: 1642424351     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300417-JLR200     Document Type: Article

References (53)

1. Gordon, D. J., and B. M. Rifkind. 1989. High density lipoprotein. The clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
2. Tall, A. R. 1998. An overview of reverse cholesterol transport. Eur. Heart J. 19 (Suppl. A): 31-35.
3. Pieters, M. N., D. Schouten, and T. Van Berkel. 1994. In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport. Biochim. Biophys. Acta. 1225: 125-134.
4. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
5. Cheung, M. C., and J. J. Albers. 1984. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-I1 and particles containing A-1 but no A-1I. J. Biol. Chem. 259: 12202-12209.
6. Blanco-Vaca, F., J. C. Escola-Gil, J. M. Martin-Campos, and J. Julve. 2001. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J. Lipid Res. 42: 1727-1739.
7. Kalopissis, A. D., D. Pastier, and J. Chambaz. 2003. Apolipoprotein A-11: beyond genetic associations with lipid disorders and insulin resistance. Curr. Opin. Lipidol. 14: 165-172.
8. Warden, C. H., C. C. Hedrick, J. H. Qiao, L. W. Castellani, and A. J. Lusis. 1993. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-11. Science. 261: 469-472.
9. Weng, W., and J. L. Breslow. 1996. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc. Natl. Acad. Sci. USA. 93: 14788-14794.
10. Escola-Gil, J. C., A. Marzal-Casacuberta, J. Julve-Gil, B. Y. Ishida, J. Ordonez-Llanos, L. Chan, F. Gonzales-Sastre, and F. Blanco-Vaca. 1998. Human apolipoprotein A-II is a pro-arthrogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet. J. Lipid Res. 39: 457-462.
11. Escola-Gil, J. C., J. Julve, A. Marzal-Casacuberta, J. Ordonez-Llanos, F. Gonzalez-Sastre, and F. Blanco-Vaca. 2000. Expression of human apolipoprotein A-11 in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia. J. Lipid Res. 41: 1328-1338.
12. Escola-Gil, J. C., J. Julve, A. Marzal-Casacuberta, J. Ordonez-Llanos, F. Gonzalez-Sastre, and F. Blanco-Vaca. 2001. ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance. J. Lipid Res. 42: 241-248.
13. Schultz, J. R., J. G. Verstuyft, E. L. Gong, A. V. Nichols, and E. M. Rubin. 1993. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature. 365: 762-764.
14. Tailleux, A., M. Bouly, G. Luc, G. Castro, J. M. Caillaud, N. Hennuyer, P. Poulain, J. C. Fruchart, N. Duverger, and C. Fievet. 2000. Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice. Arterioscler. Thromb. Vasc. Biol. 20: 2453-2458.
15. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science. 271: 518-520.
16. Rigotti, A., H. E. Miettinen, and M. Krieger. 2003. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr. Rev. 24: 357-387.
17. Rinninger, F., M. Brundert, R. M. Budzinski, J. C. Fruchart, H. Greten, and G. R. Castro. 2003. Scavenger receptor BI (SR-BI) mediates a higher selective cholesteryl ester uptake from LpA-1 compared with LpA-I:A-1I lipoprotein particles. Atherosclerosis. 166: 31-40.
18. Pilon, A., O. Briand, S. Lestavel, C. Copin, Z. Majd, J. C. Fruchart, G. Castro, and V. Clavey. 2000. Apolipoprotein AII enrichment of HDL enhances their affinity for class B type 1 scavenger receptor but inhibits specific cholesteryl ester uptake. Arterioscler. Thromb. Vasc. Biol. 20: 1074-1081.
19. de Beer, M. C., D. M. Durbin, L. Cai, N. Mirocha, A. Jonas, N. R. Webb, F. C. de Beer, and D. R. van der Westhuyzen. 2001. Apolipoprotein A-11 modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor B1. J. Biol. Chem. 276: 15832-15839.
20. Rader, D. J., G. Castro, L. A. Zech, J. C. Fruchart, and H. B. Brewer, Jr. 1991. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-1 and LpA-1,A-11. J. Lipid Res. 32: 1849-1859.
21. Pieters, M. N., G. R. Castro, D. Schouten, P. Duchateau, J. C. Fruchart, and T. J. Van Berkel. 1993. Cholesterol esters selectively delivered in vivo by high-density-lipoprotein subclass LpA-I to rat liver are processed faster into bile acids than are LpA-I/A-II-derived cholesterol esters. Biochem. J. 292: 819-823.
22. Febbraio, M., D. P. Haijar, and R. L. Silverstein. 2001. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108: 785-791.
23. Connelly, M. A., S. M. Klein, S. Azhar, N. A. Abumrad, and D. L. Williams. 1999. Comparison of class B scavenger receptors, CD36 and scavenger receptor B1 (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-B1 exhibits a unique enhancement of cholesteryl ester uptake. J. Biol. Chem. 274: 41-47.
24. de Villiers, W. J., L. Cai, N. R. Webb, M. C. de Beer, D. R. van der Westhuyzen, and F. C. de Beer. 2001. CD36 does not play a direct role in HDL or LDL metabolism. J. Lipid Res. 42: 1231-1238.
25. Febbraio, M., N. A. Abumrad, D. P. Hajjar, K. Sharma, W. Cheng, S. F. Pearce, and R. L. Silverstein. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274: 19055-19062.
26. Aitman, T. J., A. M. Glazier, C. A. Wallace, L. D. Cooper, P. J. Norsworthy, F. N. Wahid, K. M. Al-Majali, P. M. Trembling, C. J. Mann, C. C. Shoulders, D. Graf, E. St. Lezin, T. W. Kurtz, V. Kren, M. Pravenec, A. Ibrahimi, N. A. Abumrad, L. W. Stanton, and J. Scott. 1999. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21: 76-83.
27. Castellani, L. W., A. M. Goto, and A. J. Lusis. 2001. Studies with apolipoprotein A-1I transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes. 50: 643-651.
28. Weng, W., N. A. Brandenburg, S. Zhong, J. Halkais, L. Wu, X. Jiang, A. Tall, and J. L. Breslow. 1999. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase: studies in apoA-II and hepatic lipase double knockout mice. J. Lipid Res. 40: 1064-1070.
29. Coetzee, G. A., A. F. Strachan, D. R. van der Westhuyzen, H. C. Hoppe, M. S. Jeenah, and F. C. de Beer. 1986. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J. Biol. Chem. 261: 9644-9651.
30. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
31. Bilheimer, D. W., S. Eisenberg, and R. I. Levy. 1972. The metabolism of very low density lipoproteins. I. Preliminary in vitro and in vivo observations. Biochim. Biophys. Acta. 260: 212-221.
32. Cai, L., E. R. Eckhardt, W. Shi, Z. Zhao, M. Nasser, W. J. De Villiers, and D. R. van der Westhuyzen. 2003. Scavenger receptor class B type I reduces cholesterol absorption in cultured enterocyte CaCo-2 cells. J Lipid Res. In press.
33. Markwell, M. A., S. M. Haas, L. L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210.
34. Pownall, H. J., and J. B. Massey. 1986. Spectroscopic studies of lipoproteins. Methods Enzymol. 128: 515-518.
35. Matz, C. E., and A. Jonas. 1982. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257: 4535-4540.
36. Webb, N. R., P. M. Connell, G. A. Graf, E.J. Smart, W. J. S. Villiers, F. C. de Beer, and D. R. van der Westhuyzen. 1998. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J. Biol. Chem. 273: 15241-15248.
37. Webb, N. R., M. C. de Beer, D. R. van der Westhuyzen, M. S. Kindy, C. L. Banka, K. Tsukamoto, D. L. Rader, and F. C. de Beer. 1997. Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I-deficient mice. J. Lipid Res. 38: 1583-1590.
38. Hedrick, C. C., L. W. Castellani, C. H. Warden, D. L. Puppione, and A. J. Lusis. 1993. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. J. Biol. Chem. 268: 20676-20682.
39. de Beer, M. C., D. M. Durbin, L. Cai, A. Jonas, F. C. de Beer, and D. R. van der Westhuyzen. 2001. Apolipoprotein A-I conformation markedly influences HDL interaction with scavenger receptor BI. J. Lipid Res. 42: 309-313.
40. Liadaki, K. N., T. Liu, S. Xu, B. Y. Ishida, P. N. Duchateaux, J. P. Krieger, J. Kane, M. Krieger, and V. I. Zannis. 2000. Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor class B type I. Effect of lipid association and APOA-I mutations on receptor binding. J. Biol. Chem. 275: 21262-21271.
41. Webb, N. R., W. J. S. De Villiers, P. M. Connell, F. C. de Beer, and D. R. van der Westhuyzen. 1997. Alternative forms of scavenger receptor BI (SR-BI). J. Lipid Res. 38: 1490-1495.
42. Gu, X., B. Trigatti, S. Xu, S. Acton, J. Babitt, and M. Krieger. 1998. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J. Biol. Chem. 273: 26338-26348.
43. Durbin, D. M., and A. Jonas. 1997. The effect of apolipoprotein A-II on the structure and function of apolipoprotein A-I in a homogeneous reconstituted high density lipoprotein particle. J. Biol. Chem. 272: 31333-31339.
44. Thuahnai, S. T., S. Lund-Katz, G. M. Anantharamaiah, D. L. Williams, and M. C. Phillips. 2003. A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins. J. Lipid Res. 44: 1132-1142.
45. Gu, X., R. Lawrence, and M. Krieger. 2000. Dissociation of the high density lipoprotein and low density lipoprotein binding activities of murine scavenger receptor class B type I (mSR-BI) using retrovirus library-based activity dissection. J. Biol. Chem. 275: 9120-9130.
46. Temel, R. E., R. L. Walzem, C. L. Banka, and D. L. Williams. 2002. Apolipoprotein A-I is necessary for the in vivo formation of high density lipoprotein competent for scavenger receptor BI-mediated cholesteryl ester-selective uptake. J. Biol. Chem. 277: 26565-26572.
47. Nieland, T. J., M. Penman, L. Dori, M. Krieger, and T. Kirchhausen. 2002. Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. Proc. Natl. Acad. Sci. USA. 99: 15422-15427.
48. Schultz, J. R., E. L. Gong, M. R. McCall, A. V. Nichols, S. M. Clift, and E. M. Rubin. 1992. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. J. Biol. Chem. 267: 21630-21636.
49. von Eckardstein, A., G. Castro, I. Wybranska, N. Theret, P. Duchateau, J-C. Fruchart, G. Ailhaud, and G. Assmann. 1993. Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. J. Biol. Chem. 268: 2616-2622.
50. Fidge, N. H. 1999. High density lipoprotein receptors, binding proteins, and ligands. J. Lipid Res. 40: 187-201.
51. Grewal, T., I. De Diego, M. F. Kirchhoff, F. Tebar, J. Heeren, F. Rinninger, and C. Enrich. 2003. High density lipoprotein-induced signalling of MAPK pathway involves scavenger receptor type BI-mediated activation of Ras. J. Biol. Chem. 278: 16478-16481.
52. Yuhanna, I. S., Y. Zhu, B. E. Cox, L. D. Hahner, S. Osborne-Lawrence, P. Lu, Y. L. Marcel, R. G. Anderson, M. E. Mendelsohn, H. H. Hobbs, and P. W. Shaul. 2001. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat. Med. 7: 853-857.
53. Gong, M., M. Wilson, T. Kelly, W. Su, J. Dressman, J. Kincer, S. V. Matveev, L. Guo, T. Guerin, X. A. Li, W. Zhu, A. Uittenbogaard, and E. J. Smart. 2003. HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J. Clin. Invest. 111: 1579-1587.